GRUSF
Price
$0.41
Change
+$0.01 (+2.50%)
Updated
Jan 14 closing price
Capitalization
104.23M
Intraday BUY SELL Signals
HKMPF
Price
$20.79
Change
-$0.15 (-0.72%)
Updated
Jan 6 closing price
Capitalization
4.57B
Intraday BUY SELL Signals
Interact to see
Advertisement

GRUSF vs HKMPF

Header iconGRUSF vs HKMPF Comparison
Open Charts GRUSF vs HKMPFBanner chart's image
Grown Rogue International
Price$0.41
Change+$0.01 (+2.50%)
Volume$56.27K
Capitalization104.23M
Hikma Pharmaceuticals
Price$20.79
Change-$0.15 (-0.72%)
Volume$600
Capitalization4.57B
GRUSF vs HKMPF Comparison Chart in %
GRUSF
Daily Signal:
Gain/Loss:
HKMPF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
GRUSF vs. HKMPF commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRUSF is a Hold and HKMPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (GRUSF: $0.41 vs. HKMPF: $20.79)
Brand notoriety: GRUSF and HKMPF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: GRUSF: 24% vs. HKMPF: 93%
Market capitalization -- GRUSF: $104.23M vs. HKMPF: $4.57B
GRUSF [@Pharmaceuticals: Generic] is valued at $104.23M. HKMPF’s [@Pharmaceuticals: Generic] market capitalization is $4.57B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $65.17B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRUSF’s FA Score shows that 1 FA rating(s) are green whileHKMPF’s FA Score has 1 green FA rating(s).

  • GRUSF’s FA Score: 1 green, 4 red.
  • HKMPF’s FA Score: 1 green, 4 red.
According to our system of comparison, GRUSF is a better buy in the long-term than HKMPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRUSF’s TA Score shows that 5 TA indicator(s) are bullish while HKMPF’s TA Score has 3 bullish TA indicator(s).

  • GRUSF’s TA Score: 5 bullish, 5 bearish.
  • HKMPF’s TA Score: 3 bullish, 1 bearish.
According to our system of comparison, HKMPF is a better buy in the short-term than GRUSF.

Price Growth

GRUSF (@Pharmaceuticals: Generic) experienced а -9.82% price change this week, while HKMPF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -0.60%. For the same industry, the average monthly price growth was +8.77%, and the average quarterly price growth was +19.20%.

Industries' Descriptions

@Pharmaceuticals: Generic (-0.60% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HKMPF($4.57B) has a higher market cap than GRUSF($104M). GRUSF has higher P/E ratio than HKMPF: GRUSF (13.59) vs HKMPF (12.45). HKMPF YTD gains are higher at: -0.716 vs. GRUSF (-20.973). HKMPF has higher annual earnings (EBITDA): 734M vs. GRUSF (12.3M). HKMPF has more cash in the bank: 236M vs. GRUSF (13.1M). GRUSF has less debt than HKMPF: GRUSF (17.4M) vs HKMPF (1.56B). HKMPF has higher revenues than GRUSF: HKMPF (3.22B) vs GRUSF (22.2M).
GRUSFHKMPFGRUSF / HKMPF
Capitalization104M4.57B2%
EBITDA12.3M734M2%
Gain YTD-20.973-0.7162,928%
P/E Ratio13.5912.45109%
Revenue22.2M3.22B1%
Total Cash13.1M236M6%
Total Debt17.4M1.56B1%
FUNDAMENTALS RATINGS
GRUSF vs HKMPF: Fundamental Ratings
GRUSF
HKMPF
OUTLOOK RATING
1..100
2831
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
5
Undervalued
PROFIT vs RISK RATING
1..100
62100
SMR RATING
1..100
3278
PRICE GROWTH RATING
1..100
6163
P/E GROWTH RATING
1..100
9397
SEASONALITY SCORE
1..100
7521

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HKMPF's Valuation (5) in the null industry is somewhat better than the same rating for GRUSF (58). This means that HKMPF’s stock grew somewhat faster than GRUSF’s over the last 12 months.

GRUSF's Profit vs Risk Rating (62) in the null industry is somewhat better than the same rating for HKMPF (100). This means that GRUSF’s stock grew somewhat faster than HKMPF’s over the last 12 months.

GRUSF's SMR Rating (32) in the null industry is somewhat better than the same rating for HKMPF (78). This means that GRUSF’s stock grew somewhat faster than HKMPF’s over the last 12 months.

GRUSF's Price Growth Rating (61) in the null industry is in the same range as HKMPF (63). This means that GRUSF’s stock grew similarly to HKMPF’s over the last 12 months.

GRUSF's P/E Growth Rating (93) in the null industry is in the same range as HKMPF (97). This means that GRUSF’s stock grew similarly to HKMPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GRUSFHKMPF
RSI
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
20%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
44%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
30%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
31%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
33%
Advances
ODDS (%)
Bullish Trend 16 days ago
76%
Bullish Trend 24 days ago
33%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GRUSF
Daily Signal:
Gain/Loss:
HKMPF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RGCIX9.780.06
+0.62%
Russell Inv Global Infrastructure C
HMVJX16.470.07
+0.43%
Hartford MidCap Value I
IFUTX26.960.04
+0.15%
Invesco Dividend Income R6
SPMIX27.060.03
+0.11%
Shelton S&P Midcap Index Investor
FNFWX96.82-0.26
-0.27%
American Funds New World 529-F-2

GRUSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRUSF has been loosely correlated with GLASF. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if GRUSF jumps, then GLASF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRUSF
1D Price
Change %
GRUSF100%
+1.92%
GLASF - GRUSF
34%
Loosely correlated
+0.48%
TSNDF - GRUSF
33%
Poorly correlated
+3.05%
TCNNF - GRUSF
29%
Poorly correlated
+2.18%
CURLF - GRUSF
28%
Poorly correlated
+4.56%
CRLBF - GRUSF
28%
Poorly correlated
+3.03%
More

HKMPF and

Correlation & Price change

A.I.dvisor tells us that HKMPF and AMPH have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HKMPF and AMPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HKMPF
1D Price
Change %
HKMPF100%
N/A
AMPH - HKMPF
24%
Poorly correlated
-3.98%
CAIHF - HKMPF
24%
Poorly correlated
N/A
HLTRF - HKMPF
11%
Poorly correlated
N/A
GRUSF - HKMPF
9%
Poorly correlated
+1.92%
ESALF - HKMPF
7%
Poorly correlated
+2.03%
More